Organo Stock

Organo EBIT

The EBIT of Organo (6368.T) as of Aug 2, 2026 is 31.12 B JPY. In the previous year, EBIT was 22.54 B JPY — a change of 38.04% (higher).

EBIT

31.12 BJPY

YoY

38.04%

Last updated:

In 2026, Organo's EBIT was 31.12 B JPY, a 38.04% increase from the 22.54 B JPY EBIT recorded in the previous year.

The Organo EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B JPY)
Date
EBIT (B JPY)
Jan 1, 2022
10.85 base
Jan 1, 2023
15.21 base
Jan 1, 2024
22.54 base
Jan 1, 2025
31.12 base
Jan 1, 2026 (e)
59.72 base
Jan 1, 2027 (e)
68.94 base
Jan 1, 2028 (e)
75.17 base
Jan 1, 2029 (e)
78.53 base
YEAREBIT (B JPY)
2029 est 78.53
2028 est 75.17
2027 est 68.94
2026 est 59.72
2025 31.12
2024 22.54
2023 15.21
2022 10.85
2021 9.58
2020 9.91
2019 6.56
2018 3.82
2017 4.11
2016 3.95
2015 2.40
2014 0.83
2013 3.50
2012 4.85
2011 3.53
2010 1.85
2009 3.06
2008 3.85
2007 7.52
2006 4.25
Access this data via the Eulerpool API

Organo Revenue

Organo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
112.07 B JPY
10.85 B JPY
9.21 B JPY
Jan 1, 2023
132.43 B JPY
15.21 B JPY
11.73 B JPY
Jan 1, 2024
150.36 B JPY
22.54 B JPY
17.31 B JPY
Jan 1, 2025
163.27 B JPY
31.12 B JPY
24.15 B JPY
Jan 1, 2026 (e)
175.92 B JPY
59.72 B JPY
27.63 B JPY
Jan 1, 2027 (e)
203.10 B JPY
68.94 B JPY
31.19 B JPY
Jan 1, 2028 (e)
221.43 B JPY
75.17 B JPY
34.44 B JPY
Jan 1, 2029 (e)
231.33 B JPY
78.53 B JPY
36.76 B JPY

Organo Margins

Organo stock margins

The Organo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Organo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Organo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
25.44 %
9.68 %
8.22 %
Jan 1, 2023
26.41 %
11.49 %
8.86 %
Jan 1, 2024
29.16 %
14.99 %
11.51 %
Jan 1, 2025
33.80 %
19.06 %
14.79 %
Jan 1, 2026 (e)
33.80 %
33.95 %
15.71 %
Jan 1, 2027 (e)
33.80 %
33.95 %
15.36 %
Jan 1, 2028 (e)
33.80 %
33.95 %
15.55 %
Jan 1, 2029 (e)
33.80 %
33.95 %
15.89 %

Organo Stock analysis

What does Organo do? Organo Corp is an internationally operating company specialized in the production and distribution of products in the health and wellness industry. The company was founded in Vancouver, Canada in 2008 by Bernardo Chua. Organo Corp's business model is based on network marketing to sell its products. This has allowed the company to quickly build a large customer base and become active in over 50 countries. The goal of Organo Corp is to help every customer lead a healthier and happier life. Organo Corp is divided into different divisions to offer customers a wide range of products. One of the main divisions is "Organo Gold," which offers coffee and tea products. These products are based on traditional Asian herbs and fungi such as Reishi, Ganoderma, and Cordyceps. These herbs have many active ingredients that strengthen the immune system, increase energy levels, reduce stress, and promote overall well-being. Another division of Organo Corp is "Organo Essentials," which offers products for a healthy everyday life. This includes supplements such as multivitamin tablets, protein powder, and Omega-3 fatty acids. These supplements are made from high-quality ingredients and aim to improve overall well-being. Organo Corp also has a "Personal Care" division, which offers products for personal hygiene. These include soaps, shampoos, creams, and lotions. These products contain natural ingredients such as tea tree oil, aloe vera, shea butter, and various essential oils that are intended to nourish and protect the skin. The company also has an "Organo Graphics" division, which offers marketing materials to help independent distributors of Organo Corp build their own business. This includes brochures, business cards, and sales tools. Organo Corp has also made a name for itself through various philanthropic activities. The company has established the "OG Care Foundation," which advocates for disadvantaged children and their families worldwide. The foundation supports projects in the areas of education, health, and well-being. In summary, Organo Corp is a company specializing in the sale of products in the health and wellness industry. The company offers a wide range of products based on natural ingredients such as Asian herbs and fungi. Through network marketing, Organo Corp has quickly built a large customer base and is now active in over 50 countries. Additionally, the company is committed to supporting disadvantaged children around the world through the "OG Care Foundation." Organo is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Organo's EBIT

Organo's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Organo's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Organo's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Organo’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Organo stock

EBIT of Organo is 31.12 B JPY in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Organo

All Key Metrics — Organo